Drug Search Results
More Filters [+]

Vapitadine

Alternative Names: vapitadine, Hivenyl
Latest Update: 2024-05-10
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: H1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Barrier nv
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Vapitadine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Urticaria

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

oral treatment with R129160 (60 mg o.d.) in patients with chronic idiopathic urticaria

P2

Completed

Urticaria

2009-01-18

Recent News Events